Basic cancer research: why is it essential for the success of personalised cancer therapy?

Professors Carlos Caldas and Yosef Yarden recently wrote a position paper on the behalf of the EACR, which was published in the European Journal of Cancer (EJC). It describes the "irreplaceable leading role" of basic research in the future of cancer therapy, and how allocating resources to basic studies could be the key to unlocking new achievements in personalised treatment.

Click here to read the 2-page position paper (reprinted in the 2014 EACR Yearbook)

Click here to view the Pubmed listing for the article